2023
DOI: 10.1080/14740338.2023.2181954
|View full text |Cite
|
Sign up to set email alerts
|

Medication errors during a pandemic: what have we learnt?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 25 publications
0
1
0
Order By: Relevance
“…Studies referring to intermediate care units or pediatric and neonatal intensive care units were excluded. The exclusion of COVID-19-related studies is due to the heightened risk of medication errors during pandemics, which may stem from systemic failures, inadequate preparedness, increased staff stress, attrition, and emerging clinical complexities, necessitating distinct approaches to error mitigation [ 24 ].…”
Section: Methodsmentioning
confidence: 99%
“…Studies referring to intermediate care units or pediatric and neonatal intensive care units were excluded. The exclusion of COVID-19-related studies is due to the heightened risk of medication errors during pandemics, which may stem from systemic failures, inadequate preparedness, increased staff stress, attrition, and emerging clinical complexities, necessitating distinct approaches to error mitigation [ 24 ].…”
Section: Methodsmentioning
confidence: 99%
“…Studies referring to intermediate care units or pediatric and neonatal intensive care units will not be included. Studies conducted in adult ICUs directly involved in the COVID-19 response will be excluded because the risk of medication errors may be higher during times of pandemic due to system failures, inefficient preparedness plans, staff stress and attrition as well as new clinical complexities, requiring differentiated mitigation responses [ 36 ].…”
Section: Inclusion Criteriamentioning
confidence: 99%
“…Pharmacists’ services have evolved from mere drug dispensing to more individualised and specialised patient care to align with institutional goals and best practices (Al Aqeel et al, 2018 ; Al Meslamani, 2023a , 2023b ; Presley et al, 2019 ). They follow evidence-based guidelines, formulate local guidelines, design drug use policies, diminish medication errors, champion medication safety initiatives, and assist in treatment decisions (Kassem et al, 2021 ; Lee et al, 2017 ; Stasiak et al, 2014 ; Van der Linden et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%